Literature DB >> 9694195

Age-related changes in human optokinetic function.

A J Matheson1, C L Darlington, P F Smith.   

Abstract

The aim of the present study was to investigate the effects of ageing on optokinetic function in labyrinthine-intact human subjects. Subjects aged 18-39 years, 40-59 years and > or = 60 years were tested for sensitivity to optokinetic stimulation using latency to the illusion of circularvection in an optokinetic drum. The latency to circularvection significantly increased with increasing age. These results suggest a decline in optokinetic sensitivity with increasing age, which may be related to age-related deterioration in the optokinetic visual pathways.

Entities:  

Mesh:

Year:  1998        PMID: 9694195     DOI: 10.1097/00001756-199807130-00005

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Sensorimotor and cognitive factors associated with the age-related increase of visual field dependence: a cross-sectional study.

Authors:  Catherine P Agathos; Delphine Bernardin; Delphine Huchet; Anne-Catherine Scherlen; Christine Assaiante; Brice Isableu
Journal:  Age (Dordr)       Date:  2015-06-30

2.  Age related change of optokinetic nystagmus in healthy subjects: a study from infancy to senescence.

Authors:  C Valmaggia; A Rütsche; A Baumann; C Pieh; Y Bellaiche Shavit; F Proudlock; I Gottlob
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

3.  Vestibular asymmetry predicts falls among elderly patients with multi-sensory dizziness.

Authors:  Eva Ekvall Hansson; Måns Magnusson
Journal:  BMC Geriatr       Date:  2013-07-22       Impact factor: 3.921

4.  Genetic background influences age-related decline in visual and nonvisual retinal responses, circadian rhythms, and sleep.

Authors:  Gareth Banks; Ines Heise; Becky Starbuck; Tamzin Osborne; Laura Wisby; Paul Potter; Ian J Jackson; Russell G Foster; Stuart N Peirson; Patrick M Nolan
Journal:  Neurobiol Aging       Date:  2014-08-02       Impact factor: 4.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.